Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ)

17.83 -0.03 (-0.17%) As of 10:18AM CST. Market open.

Zhejiang Tailin BioEngineering Co.,Ltd

NO. 2930, Nanhuan Road
Binjiang District
Hangzhou 310052
China
86 571 8658 9087
https://www.tailingood.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Da Lin Ye	GM & Chairman	N/A	N/A	1960
Mr. Xing Yue Ye	CFO & Secretary of the Board	N/A	N/A	1974
Mr. Zhi Lin Shen	Deputy GM & Director	N/A	N/A	1971
Mr. Xin Qun Xia	Deputy GM & Director	N/A	N/A	1967

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Zhejiang Tailin BioEngineering Co.,Ltd manufactures microbial test and control equipment, mainly for pharmaceutical and medical sector. The company offers sterility testing equipment, microbiological testing equipment, TOC analyzers, sterile isolation systems, hydrogen peroxide sterilization systems, sterile delivery system, and filters, as well as technical services. Its products are primarily used in bio-pharmaceutical, medical, disease control, food, environmental protection, electronics, and other fields, as well as in bio-security equipment manufacturing industries. The company was formerly known as Hangzhou Tailin Biotechnology Equipment Co., Ltd. and changed its name to Zhejiang Tailin BioEngineering Co.,Ltd in April 2015. Zhejiang Tailin BioEngineering Co.,Ltd was founded in 1993 and is based in Hangzhou, China.

Corporate governance

Zhejiang Tailin BioEngineering Co.,Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.